The stock gave great results on QOQ basis with from a loss of 8 lakhs to a profit of 14.5 crore thats good on every scale.
The only thing that concerns me is the which is way above the Industry average of 20.
**Credit Rating for Marksans Pharma **
for Long Term Rating from fitch
for Short Term from fitch
The stock has a major support around 35–39 levels if these levels are breached one can exit the stock. But stock appears lucrative at current price for 52 targets and would complete pattern